WO2014041124A1 - Matrice d'immobilisation comprenant une couche de tétraétherlipides, procédé pour la produire et puce de biocapteur comprenant cette matrice d'immobilisation - Google Patents

Matrice d'immobilisation comprenant une couche de tétraétherlipides, procédé pour la produire et puce de biocapteur comprenant cette matrice d'immobilisation Download PDF

Info

Publication number
WO2014041124A1
WO2014041124A1 PCT/EP2013/069011 EP2013069011W WO2014041124A1 WO 2014041124 A1 WO2014041124 A1 WO 2014041124A1 EP 2013069011 W EP2013069011 W EP 2013069011W WO 2014041124 A1 WO2014041124 A1 WO 2014041124A1
Authority
WO
WIPO (PCT)
Prior art keywords
lipid
protein
immobilization matrix
aqueous suspension
biosensor chip
Prior art date
Application number
PCT/EP2013/069011
Other languages
German (de)
English (en)
Inventor
Christian BÜCHER
Klaus Liefeith
Original Assignee
Institut Für Bioprozess- Und Analysenmesstechnik E. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Für Bioprozess- Und Analysenmesstechnik E. V. filed Critical Institut Für Bioprozess- Und Analysenmesstechnik E. V.
Publication of WO2014041124A1 publication Critical patent/WO2014041124A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules

Definitions

  • tetraetheripids with their natural head group structure are not suitable for covalent bonding to material surfaces, but lipidation of material surfaces under specific conditions is only possible by targeted activation of their head groups.
  • DE 102 28 857 A1 describes tetraetheripids with small head groups which are said to be suitable for covalent bonding to certain surfaces.
  • the tetraether lipids in this document are chemically derivatives of caldarchaeol. Caldarchaeol is the hydrolysis product of the main phospholipid from the archaebacterium Thermoplasma acidophilum.
  • lipidation using organic solvents is not an option for broad industrial application. It has been shown that no vesicles could be produced in the aqueous medium with caldarchaeol and also with dieducationated Caldarchaeol and so Caldarchaeol is not suitable for lipidation in aqueous medium. It is the object of the present invention to provide easy-to-handle tetraether lipid-based biosensor chips for chip-based analytical methods.
  • the underlying immobilization matrix should be producible by means of lipidation of material surfaces in aqueous medium by self-assembly.
  • the prepared lipid layers of the matrix should be stable and allow efficient coupling of ligands, preferably proteins.
  • the biochips produced in this way are said to have high sensitivities and low proportions of non-specific bonds.
  • the object of the present invention is achieved according to independent claims 1, 5, 11 and 14.
  • the subclaims represent preferred embodiments. Glasses, z. Borosilicate glasses (eg Borofloat®33, Schott Jena AG, Germany) or glasses with a layered structure of Borofloat® 33 glass, tantalum (V) oxide and SiOx (BIAffinity chips, LOS Jenoptik, Jena, Germany) used.
  • the immobilization matrix is formed by contacting the solid substrate which is at least partially aminated
  • aqueous suspension of unilameilar lipid vesicles of tetraether of general formula I is preferably carried out for 2 to 15 hours, more preferably 9 to 15 hours, at ambient temperature.
  • ambient temperature is understood to mean 15-29 ° C., preferably 18-25 ° C.
  • concentration of the aqueous suspension of unilameilar vesicles is preferably from 1 to 10 mg / ml, more preferably from 2 to 4 mg / ml.
  • the thus-immobilized matrix is subsequently tempered.
  • the annealing may be carried out, for example, at 80 to 80 ° C for one to three hours, preferably at 70 ° C for two hours.
  • the aqueous suspension of the unilamellar vesicles of the tetraether lipid of the general formula I is prepared by repeated extrusion, preferably 1 to 21 times, extrusion of an aqueous suspension of multilamellar lipid vesicles of this tetraether lipid through a polycarbonate membrane of desired and defined pore size.
  • the pore size is preferably between 100 and 1000 nm. More preferably, a polycarbonate membrane of 100 nm is used so that lipid vesicles having a defined hydrodynamic diameter of 100 nm can be produced.
  • Tetraether lipid of the general formula 1 is carried out by hydration of an evaporated lipid film and subsequent treatment in an ultrasonic bath.
  • the treatment in the ultrasonic bath may preferably be carried out at a temperature between 50 and 70 ° C, in particular at about 60 ° C and preferably for a period between 10 and 20 minutes, preferably for 15 minutes.
  • the final lipid concentration of the aqueous suspension is preferably 1 to 10 mg / ml, more preferably 2 to 4 mg / ml.
  • the surface of the solid substrate used in addition to the gold, silver or copper surface, the surface of the solid substrate used must be at least partially aminated to ensure the reliable Anfeindung the Cyanurchloridrestes on the amino group. Methods for the amination of surfaces are known.
  • the amination of the surface can be achieved for example by a plasma activation or by incubation with an amino-functional silane.
  • an aminoalkylsilane can be used, with particular preference being given to 3-aminopropyldimethylethoxysilane, 3-aminopropyltrimethoxysilane or 3-aminopropyltriethoxysilane.
  • the immobilization matrix of claim 1 and its preferred embodiments for producing a biosensor chip is also an object of the present invention.
  • biosensor chips are referred to as carrier materials which comprise the immobilization matrix according to the invention to which ligands, for example proteins, are bound.
  • the ligands are able to bind to specific target molecules (targets) and the target molecules can be detected and / or influenced in this way, so that biochemical evidence or label-free optical biomolecular interaction analyzes (RlfS, SPR) are possible.
  • the biosensor chips of the present invention are suitable for reflectometric interference spectroscopy (RIfS).
  • the biochips of the present invention have the advantage that they are storage and acid stable, do not swell and thus do not require equilibration time.
  • a ligand preferably a protein having at least one free NH 2 group, covalently, optionally via spacers, to the cyanuric chloride, thiol or 1, 2-dithiolan-3-yl -Rest bound to the monomolecular tetraether lipid layer of Immobilmaschinesmatrix.
  • the immobilization matrix is incubated with a buffer solution of the ligand. This can be performed, for example so that a continuous liquid flow is preferably particularly preferably passed for 20 to 40 minutes, "25 minutes on the lipid matrix.
  • the flow rate should be in the range of 5 ⁇ / min to 10 ⁇ / min.
  • a BIAffinity® flux (Analytik Jena AG, Germany) may be used for this purpose.
  • proteins can be attached. Streptavidin, C-reactive protein, protein G, protein A, His-tag or GFP binding protein (GBP) are particularly preferably bound according to the invention as ligands, and the corresponding protein chips are thus produced.
  • GFP GFP binding protein
  • the non-specific binding sites can be blocked very well with BSA.
  • a BSA solution with a concentration of 80-100 pg / ml BSA is used in the particular buffer used to bind the ligands (in particular PBS or acetate buffer).
  • biosensor chips of the present invention are highly sensitive and show low levels of non-specific binding events.
  • the invention will be explained in more detail below with reference to embodiments, without limiting it thereto.
  • Example 1 Isolation of the Main Phospholipid (MPL) from the Archea Dry Mass of Sulfolobus acidocaldarius and Activation of the Lipid Head Groups with Cyanuric Chloride
  • the terminal hydroxyl groups of the MPL were activated with cyanuric chloride.
  • the lipid was dissolved in chloroform and NaHCO 3 (1.5 g per 100 mg lipid) was added. The mixture was stirred at reflux for 1 hour. Subsequently, 5 eq. Add cyanuric chloride and heat at reflux for one week. The course of the reaction was monitored by thin-layer chromatography, R f values (eluent: petroiether / diethyl ether / glacial acetic acid 5/5 / 0.1) of 0.67 ⁇ 0.0173 for the pure MPL and 0.75 ⁇ 0.0824 were found for the activated MPL.
  • Hydrodynamic diameters of diaactivated sulfolobus MPL liposomes before (right curve) and after (left curve) of extrusion In the figure above, the hydrodynamic diameters of the dicotivated sulfolobus MPLs are shown and it becomes clear that with this lipid vesicles with defined diameters of 100 nm.
  • Example 3 Amination of glass surfaces and Liposomenspreitung for the amination, the glass substrates (Borofloat ® 33 or BIAffinity chips) were placed in a specially made PTFE chamber.
  • a chloroform solution was prepared with 1% by volume of aminopropyldimethyfethoxysilane (APDMES).
  • APDMES aminopropyldimethyfethoxysilane
  • the chamber was completely filled with the silane solution and sealed with a lid.
  • the chamber was incubated overnight at 60 ° C in a drying oven. Thereafter, the chamber was taken out of the oven, and after cooling, the substrates were removed from the chamber and rinsed successively in chloroform, methanol, and water for 10 minutes each in an ultrasonic bath.
  • the glass substrates were incubated in a freshly extruded Sulfolobus MPL liposome suspension (see Example 2) overnight at room temperature. Subsequently, the substrates were again stored for two hours at 70 ° C before they Ultrasonic bath in chloroform were cleaned. The lipid substrates produced in this way had water contact angles of ⁇ 75 °.
  • Example 4 Chip Production and Functionality Testing by means of RlfS All RifS analyzes were carried out using a BIAffinity System (Analytik Jena AG, Jena, Germany). In the functionality test, the detection of the complementary analytes was carried out by means of RrfS, whereby the ratio nonspecificity / specificity was quantified. In addition, the chip modifications were tested for regenerability and the cycle stability of the bond-active surface was tested. Finally, the kinetic parameters such as the dissociation constant K D were determined and compared with the literature values.
  • the ligands (catcher molecules) streptavidin (Biomol, Hamburg, Germany), GFP binding protein (Chromotek, Kunststoff, Germany), protein G and C-reactive protein (CRP) were in the flow cell (dimension 6 mm x 1 mm x 125 ⁇ ) immobilized within the BIAffinity system on the lipidated glass transducers of Example 3. All buffers for immobilizations and measurements were degassed and filtered.
  • anti-streptavidin antibodies and a biotinylated HRP were detected as complementary analytes by means of RlfS.
  • the unspecificity was less than 20%, the chip could be regenerated into antibodies for the streptavidin / anti-streptavid system and the dissociation constant KD was consistent with the literature values.
  • GFP could be detected as complementary analyte by means of RifS.
  • the chip was regenerable.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne une matrice d'immobilisation comprenant une couche de tétraétherlipides sur laquelle des ligands (molécules de piégeage) capables de se lier à une cible peuvent être immobilisés de manière covalente. L'invention concerne également le procédé de production de cette matrice d'immobilisation, son utilisation pour produire des puces de biocapteurs, ainsi que des puces de biocapteurs comprenant cette matrice, destinées à des techniques d'analyse à base de biopuces.
PCT/EP2013/069011 2012-09-14 2013-09-13 Matrice d'immobilisation comprenant une couche de tétraétherlipides, procédé pour la produire et puce de biocapteur comprenant cette matrice d'immobilisation WO2014041124A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012216378.6 2012-09-14
DE201210216378 DE102012216378B4 (de) 2012-09-14 2012-09-14 Immobilisierungsmatrix mit Tetraetherlipidschicht, Verfahren zu deren Herstellung und Biosensorchip umfassend diese Immobilisierungsmatrix

Publications (1)

Publication Number Publication Date
WO2014041124A1 true WO2014041124A1 (fr) 2014-03-20

Family

ID=49304897

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/069011 WO2014041124A1 (fr) 2012-09-14 2013-09-13 Matrice d'immobilisation comprenant une couche de tétraétherlipides, procédé pour la produire et puce de biocapteur comprenant cette matrice d'immobilisation

Country Status (2)

Country Link
DE (1) DE102012216378B4 (fr)
WO (1) WO2014041124A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3708151A1 (fr) * 2019-03-15 2020-09-16 Technische Universität Wien Procédé de production d'une composition comprenant des lipides d'archaea provenant d'une culture de cellules de sulfolobus

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008202A1 (fr) * 1991-10-23 1993-04-29 National Research Council Of Canada Formation de liposomes stables a partir d'extraits de liposomes d'archeobacteries (archaea)
DE19607722A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Dr Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung
WO2002053554A2 (fr) * 2000-12-28 2002-07-11 Bernina Biosystems Gmbh Derives de tetraetherlipides, liposomes contenant des derives de tetraetherlipides et agglomerats lipidiques ainsi que leur utilisation
DE10228857A1 (de) 2002-06-26 2004-01-22 Surface & Interface Technologies Gmbh Rosenhof Tetraetherlipide mit kleinen Kopfgruppen, deren Herstellung und Verwendung
DE102004033667A1 (de) 2004-07-01 2006-02-02 Institut für Bioprozess- und Analysenmesstechnik e.V. Kompositmaterialien mit Tetraetherlipiden und deren Herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098588A (en) * 1989-11-29 1992-03-24 The United States Of America As Represented By The Secretary Of The Navy New class of lubricants derived from archaebacterial lipids

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008202A1 (fr) * 1991-10-23 1993-04-29 National Research Council Of Canada Formation de liposomes stables a partir d'extraits de liposomes d'archeobacteries (archaea)
DE19607722A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Dr Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung
WO2002053554A2 (fr) * 2000-12-28 2002-07-11 Bernina Biosystems Gmbh Derives de tetraetherlipides, liposomes contenant des derives de tetraetherlipides et agglomerats lipidiques ainsi que leur utilisation
DE10228857A1 (de) 2002-06-26 2004-01-22 Surface & Interface Technologies Gmbh Rosenhof Tetraetherlipide mit kleinen Kopfgruppen, deren Herstellung und Verwendung
DE102004033667A1 (de) 2004-07-01 2006-02-02 Institut für Bioprozess- und Analysenmesstechnik e.V. Kompositmaterialien mit Tetraetherlipiden und deren Herstellung

Also Published As

Publication number Publication date
DE102012216378A1 (de) 2014-03-20
DE102012216378B4 (de) 2014-05-15

Similar Documents

Publication Publication Date Title
EP0429907B1 (fr) Biocapteur optique
DE69030811T2 (de) Rezeptormembranen und selektive steuerung des ionenflusses durch ionophoren
US8551332B2 (en) Affinity particle and affinity separation method
WO2007106483A2 (fr) Fibre polymere a canaux capillaires en tant que supports d'extraction en phase solide
DE3882797T2 (de) Schwach affinitives Adsorbens für Affinitätschromatographie.
EP3484612B1 (fr) Support chromatographique comprenant des microglobules liés et son procédé de fabrication
DE10344820B4 (de) Adsorptionsmembranen, Verfahren zur Herstellung derselben und Verwendung der Adsorptionsmembranen in Vorrichtungen
DE102016004432A1 (de) Multimodales Adsorptionsmedium mit multimodalen Liganden, Verfahren zu dessen Herstellung und dessen Verwendung
Guo et al. Synthesis of nanoparticles with a combination of metal chelation and molecular imprinting for efficient and selective extraction of glycoprotein
EP0318777A2 (fr) Support d'essai pour l'analyse d'un échantillon fluide et méthode pour sa préparation
DE102012216378B4 (de) Immobilisierungsmatrix mit Tetraetherlipidschicht, Verfahren zu deren Herstellung und Biosensorchip umfassend diese Immobilisierungsmatrix
Lv et al. Fast clean-up and selective enrichment of florfenicol in milk by restricted access media molecularly imprinted magnetic microspheres based on surface-initiated photoiniferter-mediated polymerization
DE19736736A1 (de) Verfahren zur Beschichtung von Oberflächen mit definierten Molekülschichten
Maharani et al. Preparation and characterization of silica-carrageenan adsorbent for Pb2+ and Cd2+ as interfering ion
WO2009132100A2 (fr) Méthode de création d’un étalon pour plusieurs analytes présents dans une matière première d’origine biologique
EP2249157A1 (fr) Procédé de nettoyage d'au moins une substance cible devant être contrôlée
Trinh et al. Impact of double cryogelation process on a macroporous dye‐affinity hydrogel
US20130273571A1 (en) Method of functionalizing human red blood cells with antibody
DE102013014242A1 (de) Hydrolytically Stable Ion-Exchange Stationary Phases and Uses Thereof
EP3034616B1 (fr) Dispositif de fabrication et/ou de nettoyage de biomateriaux couples a des nanoparticules et son procede d'utilisation
Mallik et al. Surface modification of silica with β-alanine derivatives for unique applications in liquid chromatography
EP1644113A1 (fr) Procede pour appliquer des substances sur des particules de gel de silice non poreuses
DE10053553A1 (de) Vorrichtung zum Nachweis und zum Anreichern von Biomolekülen
Chimri et al. AMINOFUNCTIONAL SORBENTS FOR THIN LAYER CHROMATOGRAPHY
DE4013713A1 (de) Optischer biosensor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13773639

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13773639

Country of ref document: EP

Kind code of ref document: A1